Search results for "Urinary incontinence"
Behavioral therapy appears more effective than pharmacologic therapy for urinary incontinence outcomes
The systematic review and network meta-analysis compared first-, second-, and third-line pharmacologic and nonpharmacologic interventions for improvement or cure of stress, urgency, or mixed incontinence.
https://immattersacp.org/weekly/archives/2019/03/19/1.htm
19 Mar 2019
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2018/10/latest-updates-on-acps-priorities-initiatives.htm
1 Oct 2018
Large valsartan recall, new warnings for fluoroquinolones
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/09/large-valsartan-recall-new-warnings-for-fluoroquinolones.htm
1 Sep 2018
Women's health groups recommend screening all women for urinary incontinence annually
Given the prevalence of urinary incontinence, that women do not volunteer symptoms, and the multiple and frequently changing risk factors associated with incontinence, annual testing is reasonable, a clinical guideline concluded.
https://immattersacp.org/weekly/archives/2018/08/14/1.htm
14 Aug 2018
MKSAP Quiz: 1 week of urinary incontinence
An 82-year-old woman is evaluated for a 1-week history of urinary incontinence with lower abdominal discomfort. She reports no dysuria, fever, or back pain. Medical history is significant for hypertension and allergic reaction to sulfa drugs, which cause a generalized rash. Her only medication is amlodipine. Following a physical exam and urine dipstick result, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2018/07/24/3.htm
24 Jul 2018
MKSAP Quiz: 1-year history of tremor
A 56-year-old woman is evaluated for a 1-year history of tremor. The tremor is more prominent on the right side. She also reports increasing problems with balance and numerous falls, especially when arising from a chair or turning. The patient does not have any significant cognitive symptoms. Following a physical exam and cranial nerve examination, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2018/05/22/3.htm
22 May 2018
Make screening for prostate cancer an individual choice, USPSTF says
Prostate-specific antigen-based screening programs in men ages 55 to 69 years may prevent approximately 1.3 deaths from prostate cancer over approximately 13 years per 1,000 men screened, as well as approximately three cases of metastatic prostate cancer per 1,000 men screened, the U.S. Preventive Services Task Force (USPSTF) found.
https://immattersacp.org/weekly/archives/2018/05/15/1.htm
15 May 2018
Patients and priorities in prostate cancer care
Prostate cancer requires men to work through a multitude of treatment options, and if the patient ends up settling on active surveillance, then the internist's role is even more important moving forward.
https://immattersacp.org/archives/2017/11/patients-and-priorities-in-prostate-cancer-care.htm
1 Nov 2017
MKSAP Quiz: 1-week history of recurrent episodes of facial pain
A 36-year-old woman with relapsing-remitting MS is evaluated for a 1-week history of recurrent episodes of facial pain that are 1 to 3 seconds in duration and occur spontaneously dozens of times throughout the day. The pain is sharp, severe, and located in the right infraorbital area. During this same period, she has developed worsening bilateral lower extremity weakness and urinary incontinence. After a physical exam and lab studies, what is the most likely cause of the facial pain?
https://immattersacp.org/weekly/archives/2017/04/25/3.htm
25 Apr 2017
Task Force draft recommendation leaves PSA screening choice up to patients
Clinicians should talk to men ages 55 to 69 about the potential benefits and harms of screening, according to the U.S. Preventive Services Task Force. For men ages 70 years and older, the potential benefits of prostate-specific antigen (PSA)-based screening do not outweigh the harms, the Task Force said.
https://immattersacp.org/weekly/archives/2017/04/18/1.htm
18 Apr 2017